Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT-confirmed complete response.
Lisanne P ZijlkerSonja LevyWendy WoltersJohannes V van ThienenAlexander C J van AkkooiMargot E T TesselaarPublished in: Cancer (2023)
Patients with mMCC who acquire a CR on PET/CT imaging appear to have durable responses after discontinuation of treatment after 1 year.